Pharvaris N.V. (PHVS)
NASDAQ·Healthcare·Biotechnology
$33.30
+5.85%
Mkt Cap $2.20B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (12 analysts)
$43.67
Range $38.00 – $52.00
Implied Upside
+31.1%
Consensus $43.67 vs current $33.30
NASDAQ·Healthcare·Biotechnology
$33.30
+5.85%
Mkt Cap $2.20B
Buy
3
Hold
0
Sell
0
Price Target (12 analysts)
$43.67
Range $38.00 – $52.00
+31.1%
Consensus $43.67 vs current $33.30